LONDON (Reuters) - Merck & Co Inc's COVID antiviral molnupiravir hastens restoration however doesn't cut back the hospitalisation or loss...
LONDON (Reuters) - Merck & Co Inc's COVID antiviral molnupiravir hastens restoration however doesn't cut back the hospitalisation or loss...